Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Developing and Validating a Model to Forecast 5-Year Survival in Non–Small-Cell Lung Cancer Utilizing Data from the Korean Central Cancer Registry

  • By

  • Jong Hyuk Lee

  • Ho Cheol Kim

  • Kyu-Won Jung

  • Chang Min Choi

  • June 8, 2026

Share

  • 1

    Non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality, influenced by diagnosis stage and molecular biomarkers.

  • 2

    The Korea Central Cancer Registry provides a large, multicenter dataset suitable for developing predictive models for NSCLC.

  • 3

    A deep learning model was developed to predict 5-year mortality in NSCLC using nationwide data and routine clinical features.

  • 4

    The model employed a grouped-input architecture to enhance interpretability and transparency in feature contribution assessment.

  • 5

    Data preprocessing included careful handling of missing information and stratified splitting to ensure robust model training and evaluation.

Original Source(s)

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

  • by Jong Hyuk Lee, Ho Cheol Kim, Kyu-Won Jung, Chang Min Choi

  • June 8, 2026

Related Content

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

  • by

  • September 4, 2026

  • 4 min
Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms